• Most Popular
  • Most Shared

Kaken Pharmaceutical <4521.T>-1qtr group results

Tue Aug 4, 2009 12:30am EDT
 
   Aug 4 (Reuters) -
                KAKEN PHARMACEUTICAL CO LTD
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
             3 months ended  3 months ended    6 months to     Year to   
               Jun 30, 2009    Jun 30, 2008    Sep 30, 2009    Mar 31, 2010
               LATEST          YEAR-AGO        H1              LATEST    
               RESULTS         RESULTS         FORECAST        FORECAST  
 Sales              21.02           20.49           42.70           86.10   
                 (+2.6 pct)                                              
 Operating           2.99            2.96            6.10           11.30   
                 (+1.0 pct)                                              
 Recurring           2.89            2.94            5.80           10.80   
                 (-1.6 pct)                                              
 Net                 1.71            1.75            3.50            6.50   
                 (-2.7 pct)                                              
 EPS                   Y17.38          Y17.32          Y35.65          Y66.20
 NOTE - Kaken Pharmaceutical Co Ltd specialises in drugs for practitioners.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4521.TK1.



More from Reuters

Photo

Democrats gain 60th vote on health bill

WASHINGTON (Reuters) - Senate Democrats reached a compromise on Saturday with the last holdout senator that secured the 60 votes they need to pass a broad healthcare overhaul sought by President Barack Obama.

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review